TAVR Data for the Surgeon (Michael Reardon, MD)
Breaking News: Medtronic TAVR Low-Risk Clinical Trial Results Released!Подробнее
Michael J Reardon, MD on durability of TAVR in patients with aortic stenosis with Chadi Alraies, MDПодробнее
Lifetime Management of Aortic Stenosis (Kendra J. Grubb, MD, Michael Reardon, MD)Подробнее
Low Risk TAVR: What the Data Tells Us (Michael J. Reardon, MD) March 26, 2020Подробнее
Michael J. Reardon, MD: The TAVR Study for Low-Risk MortalityПодробнее
Michael J. Reardon, MD: Long-Term TAVR PlansПодробнее
TAVR: Optimizing the Choice of Prosthesis and Patient (MICHAEL J. REARDON, MD)Подробнее
1.26.23 Grand Rounds: TAVR and the Lifetime Management of Aortic Stenosis: TAVR and the Lifetime ...Подробнее
Lifetime Management of Aortic Stenosis (Kendra J Grubb, MD, Michael Reardon, MD)Подробнее
Michael J Reardon, MD - TAVR in Asymptomatic or Moderate ASПодробнее
Aortic Valve Replacement/RD-AVR (Michael Reardon, MD)Подробнее
TAVR Valves That Are Here and Valves That Are Coming (Michael Reardon, MD)Подробнее
TAVR and Valve-in-Valve (Michael Reardon, MD)Подробнее
TAVR (Michael J. Reardon, MD) - April 6th, 2017 Re-Evolution SummitПодробнее
Aortic Valve Replacement/RD-AVR (Michael Reardon, MD)Подробнее
SCAI 2017: "Expansion" in TAVRПодробнее
TAVR-Device Selection & Expanding Indications/Percutaneous Alt. Access (Michael J. Reardon, MD)Подробнее
TAVR and Valve-in-Valve (Michael Reardon, MD)Подробнее
TMVR - Hope or Hype (Michael J. Reardon, MD)Подробнее